US2003157024A1PendingUtilityA1

Ultrasound assembly for use with light activated drugs

Priority: Mar 5, 1995Filed: Nov 26, 2002Published: Aug 21, 2003
Est. expiryMar 5, 2015(expired)· nominal 20-yr term from priority
A61K 41/0047A61B 2017/00853A61B 2017/22062A61B 2017/22021A61B 2017/22088A61M 37/0092A61B 2017/22002A61N 7/00A61B 17/2202
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A kit and method for causing tissue death within a tissue site is disclosed. The kit includes a media with a light activated drug activatable upon exposure to a particular level of ultrasound energy. The kit also includes a catheter with a lumen coupled with a media delivery port through which the light activated drug can be locally delivered to the tissue site. The ultrasound transducer is configured to transmit the level of ultrasound energy which activates the light activated drug with sufficient power that the ultrasound energy can penetrate the tissue site.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for releasing a therapeutic from a microbubble, comprising: 
 providing a microbubble with a light activated drug; and    delivering ultrasound energy to the microbubble at a frequency and intensity which activates the light activated drug to cause a rupture of the microbubble.    
     
     
         2 . The method of  claim 1 , wherein the microbubble is a liposome.  
     
     
         3 . The method of  claim 1  wherein the light activated drug is the therapeutic.  
     
     
         4 . The method of  claim 1 , wherein the microbubble includes a therapeutic in addition to the light activate drug.  
     
     
         5 . The method of  claim 1 , wherein the light activated drug is coupled with a shell of the microbubble.  
     
     
         6 . The method of  claim 1 , wherein the light activated drug is enclosed within the light activated drug.  
     
     
         7 . The method of  claim 1 , wherein the light activated drug is included in a media outside the light activated drug.  
     
     
         8 . A microbubble, comprising: 
 a substrate defining a shell of the microbubble and having a thickness permitting hydraulic transport of the microbubble;    a light activated drug activatable upon exposure to ultrasound energy, activation of the light activated drug causing a disruption in the shell sufficient to cause a rupture of the microbubble; and    a therapeutic releasable from the microbubble upon rupture of the microbubble to yield a therapeutic effect.

Join the waitlist — get patent alerts

Track US2003157024A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.